Table 2.
Histopathological findings and disease recurrence
| Number or Value | |
|---|---|
| Diagnoses | |
| Pancreatic ductal adenocarcinoma | 26 |
| Common bile duct adenocarcinoma | 10 |
| Intraductal papillary mucinous neoplasia | 1 |
| Serous cystic neoplasia | 1 |
| Pancreatic neuroendocrine tumor | 5 |
| Chronic pancreatitis | 2 |
| Tumor stage (n = 41)a | |
| 1 | 0 |
| 2 | 2 |
| 3 | 39 |
| 4 | 0 |
| Lymph node status (positive/negative) n = 41 | 30/11 |
| Lymph node ratio (<0,2/≥0,2) n = 41 | 23/18 |
| Tumor size, mm; mean (±SD) | 45 ± 37 |
| R-status (R0/R1), n = 41 | 15/26 |
| Recurrence (yes/no), n = 41 | 30/11 |
| Site of recurrence | |
| Local only | 13 |
| Distant only | 8 |
| Local and distant | 9 |
| Survival, PDAC, months; median (IQR) | 17 (13–31) |
| Survival, CBDCa, months; median (IQR) | 17 (5–27) |
| Disease-free survival, PDAC, months; median (IQR) | 12 (8–17.5) |
| Disease-free survival, CBDCa, months; median (IQR) | 9 (4–21) |
| Follow-up, entire study population, months; median (IQR) | 13 (7–30) |
| Time to last CT, months; median (IQR) | 8 (4.5–16.5) |
a
UICC, TNM classification of malignant tumors. 7th. Ed. Oxford:Wiley-Blackwell, 2009.